PineTree Therapeutics Inc

Pinetree Therapeutics is an award-winning, pre-clinical stage biotechnology company based in Cambridge, Massachusetts. Dedicated to addressing unmet medical needs, such as drug resistance and tumor recurrence in targeted therapy, Pinetree Therapeutics is advancing the field with its novel AbReptorTM platform. While the primary focus is on oncology, Pinetree Therapeutics is expanding pipelines to other areas as well. The AbReptorTM platform enables the development of multi-specific antibodies designed to outperform conventional inhibitors and ADCs (Antibody Drug Conjugate) by degradation. Unlike traditional inhibitors, which are limited in their mechanism of action (blocking the signaling pathway), our antibodies demonstrate superior efficacy in targeting...

Oncology,nsclc,solid cancer,pancreatic cancer,bispecific antibody,and breast cancer

Pinetree therapeutics inc operates in the Biotechnology industry.

Pinetree therapeutics inc's revenue is 1m - 10m

Pinetree therapeutics inc has 11 - 50 employees.